3
|
Tang S, Zhang X, Sun J, Niu D, Chruma JJ. 2-Azaallyl Anions, 2-Azaallyl Cations, 2-Azaallyl Radicals, and Azomethine Ylides. Chem Rev 2018; 118:10393-10457. [PMID: 30302999 DOI: 10.1021/acs.chemrev.8b00349] [Citation(s) in RCA: 164] [Impact Index Per Article: 27.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
This review covers the use of 2-azaallyl anions, 2-azaallyl cations, and 2-azaallyl radicals in organic synthesis up through June 2018. Particular attention is paid to both foundational studies and recent advances over the past decade involving semistabilized and nonstabilized 2-azaallyl anions as key intermediates in various carbon-carbon and carbon-heteroatom bond-forming processes. Both transition-metal-catalyzed and transition-metal-free transformations are covered. Azomethine ylides, which have received significant attention elsewhere, are discussed briefly with the primary focus on critical comparisons with 2-azaallyl anions in regard to generation and use.
Collapse
Affiliation(s)
- Shaojian Tang
- Key Laboratory of Green Chemistry & Technology (MOE), College of Chemistry, Sino-British Materials Research Institute, College of Physical Sciences & Technology, and State Key Laboratory of Biotherapy, West China Hospital , Sichuan University , Chengdu , Sichuan 610064 , People's Republic of China
| | - Xia Zhang
- Key Laboratory of Green Chemistry & Technology (MOE), College of Chemistry, Sino-British Materials Research Institute, College of Physical Sciences & Technology, and State Key Laboratory of Biotherapy, West China Hospital , Sichuan University , Chengdu , Sichuan 610064 , People's Republic of China
| | - Jiayue Sun
- Key Laboratory of Green Chemistry & Technology (MOE), College of Chemistry, Sino-British Materials Research Institute, College of Physical Sciences & Technology, and State Key Laboratory of Biotherapy, West China Hospital , Sichuan University , Chengdu , Sichuan 610064 , People's Republic of China
| | - Dawen Niu
- Key Laboratory of Green Chemistry & Technology (MOE), College of Chemistry, Sino-British Materials Research Institute, College of Physical Sciences & Technology, and State Key Laboratory of Biotherapy, West China Hospital , Sichuan University , Chengdu , Sichuan 610064 , People's Republic of China
| | - Jason J Chruma
- Key Laboratory of Green Chemistry & Technology (MOE), College of Chemistry, Sino-British Materials Research Institute, College of Physical Sciences & Technology, and State Key Laboratory of Biotherapy, West China Hospital , Sichuan University , Chengdu , Sichuan 610064 , People's Republic of China
| |
Collapse
|
4
|
Starosotnikov AM, Bastrakov MA, Kachala VV, Fedyanin IV, Shevelev SA, Dalinger IL. Unusual Pericyclic Reactivity of 4-Nitrobenzofuroxans in 1,3-Dipolar Cycloaddition with N-Benzyl Azomethine Ylide - A New Example of Multiple C-C-Bond Forming Transformations. ChemistrySelect 2018. [DOI: 10.1002/slct.201802117] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Affiliation(s)
| | - Maxim A. Bastrakov
- N.D.Zelinsky Institute of Organic Chemistry RAS; Leninsky prosp. 47 Moscow 119991 Russia
| | - Vadim V. Kachala
- N.D.Zelinsky Institute of Organic Chemistry RAS; Leninsky prosp. 47 Moscow 119991 Russia
| | - Ivan V. Fedyanin
- A.N. Nesmeyanov Institute of Organoelement Compounds RAS; Vavilova str. 28 Moscow 119991 Russia
| | - Svyatoslav A. Shevelev
- N.D.Zelinsky Institute of Organic Chemistry RAS; Leninsky prosp. 47 Moscow 119991 Russia
| | - Igor L. Dalinger
- N.D.Zelinsky Institute of Organic Chemistry RAS; Leninsky prosp. 47 Moscow 119991 Russia
| |
Collapse
|
5
|
Spanò V, Pennati M, Parrino B, Carbone A, Montalbano A, Lopergolo A, Zuco V, Cominetti D, Diana P, Cirrincione G, Zaffaroni N, Barraja P. [1,2]Oxazolo[5,4- e ]isoindoles as promising tubulin polymerization inhibitors. Eur J Med Chem 2016; 124:840-851. [DOI: 10.1016/j.ejmech.2016.09.013] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2016] [Revised: 08/31/2016] [Accepted: 09/03/2016] [Indexed: 12/20/2022]
|
7
|
Spanò V, Pennati M, Parrino B, Carbone A, Montalbano A, Cilibrasi V, Zuco V, Lopergolo A, Cominetti D, Diana P, Cirrincione G, Barraja P, Zaffaroni N. Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma. J Med Chem 2016; 59:7223-38. [PMID: 27428868 DOI: 10.1021/acs.jmedchem.6b00777] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
A series of 22 derivatives of the [1,2]oxazolo[5,4-e]isoindole system were synthesized through an efficient and versatile procedure that involves the annelation of the [1,2]oxazole moiety to the isoindole ring, producing derivatives with a wide substitution pattern. The structure-activity relationship indicates that the N-4-methoxybenzyl group appears crucial for potent activity. In addition, the presence of a 6-phenyl moiety is important and the best activity is reached with a 3,4,5-trimethoxy substituent. The most active compound, bearing both the structural features, was able to inhibit tumor cell proliferation at nanomolar concentrations when tested against the full NCI human tumor cell line panel. Interestingly, this compound was effective in reducing in vitro and in vivo cell growth, impairing cell cycle progression and inducing apoptosis, as a consequence of the inhibition of tubulin polymerization, in experimental models of diffuse malignant peritoneal mesothelioma (DMPM), a rapidly lethal disease, poorly responsive to conventional therapeutic strategies.
Collapse
Affiliation(s)
- Virginia Spanò
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo , Via Archirafi 32, 90123 Palermo, Italy
| | - Marzia Pennati
- Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori , Via Amadeo 42, 20133 Milano, Italy
| | - Barbara Parrino
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo , Via Archirafi 32, 90123 Palermo, Italy
| | - Anna Carbone
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo , Via Archirafi 32, 90123 Palermo, Italy
| | - Alessandra Montalbano
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo , Via Archirafi 32, 90123 Palermo, Italy
| | - Vincenzo Cilibrasi
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo , Via Archirafi 32, 90123 Palermo, Italy
| | - Valentina Zuco
- Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori , Via Amadeo 42, 20133 Milano, Italy
| | - Alessia Lopergolo
- Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori , Via Amadeo 42, 20133 Milano, Italy
| | - Denis Cominetti
- Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori , Via Amadeo 42, 20133 Milano, Italy
| | - Patrizia Diana
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo , Via Archirafi 32, 90123 Palermo, Italy
| | - Girolamo Cirrincione
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo , Via Archirafi 32, 90123 Palermo, Italy
| | - Paola Barraja
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo , Via Archirafi 32, 90123 Palermo, Italy
| | - Nadia Zaffaroni
- Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori , Via Amadeo 42, 20133 Milano, Italy
| |
Collapse
|